InMed Pharmaceuticals Inc (INM)

[Aladdin80]

At no point does Hsu state that they are considering a pivot to yeast. We can make various assumptions on what the "alternative approach" may be, but it does not necessarily indicate moving away from bacteria. It could be an alternative process w/the bacterial host in which expresses the proteins more effectively. What I do agree w/you is that IF it is a yeast based model it will likely be my cue to depart this investment. Between Teewinot, Librede, Willow, etc this area is overly crowded w/both patent locks and w/seasoned teams having a head start.